From: Randomized prospective phase III trial of 68Ga-PSMA-11 PET/CT molecular imaging for prostate cancer salvage radiotherapy planning [PSMA-SRT]
Author
Year
n
Response rate
Median follow-up (months)
Henkenberens
2017
23
79%
12.4
Zschaeck
20
60%
29
Emmett
99
72%
10.5
Schmidt-Hegemann
2018
129
83%
90
78%